These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 15218221

  • 1. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN, Huang CR, Lei CB, Lee PY, Chien CC, Chang HW, Chang CS, Lu CH.
    Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
    Khan ZU, Randhawa HS, Chehadeh W, Chowdhary A, Kowshik T, Chandy R.
    Int J Antimicrob Agents; 2009 Jun; 33(6):559-63. PubMed ID: 19195846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India.
    Khan ZU, Randhawa HS, Kowshik T, Chowdhary A, Chandy R.
    J Antimicrob Chemother; 2007 Aug; 60(2):312-6. PubMed ID: 17553813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.
    Perkins A, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M.
    J Antimicrob Chemother; 2005 Dec; 56(6):1144-7. PubMed ID: 16282208
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST, Tanty Haryanty T, Ng KP, Rohani MY, Hamimah H.
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [Abstract] [Full Text] [Related]

  • 11. Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
    Aller AI, Claro R, Castro C, Serrano C, Colom MF, Martín-Mazuelos E.
    Chemotherapy; 2007 Jul; 53(4):300-5. PubMed ID: 17496416
    [Abstract] [Full Text] [Related]

  • 12. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
    Bii CC, Makimura K, Abe S, Taguchi H, Mugasia OM, Revathi G, Wamae NC, Kamiya S.
    Mycoses; 2007 Jan; 50(1):25-30. PubMed ID: 17302744
    [Abstract] [Full Text] [Related]

  • 13. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ, Wu HC, Hsueh PR.
    Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
    Chandenier J, Adou-Bryn KD, Douchet C, Sar B, Kombila M, Swinne D, Thérizol-Ferly M, Buisson Y, Richard-Lenoble D.
    Eur J Clin Microbiol Infect Dis; 2004 Jun; 23(6):506-8. PubMed ID: 15141336
    [Abstract] [Full Text] [Related]

  • 15. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB, Sujatha S, Parija SC.
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [Abstract] [Full Text] [Related]

  • 16. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
    Souza LK, Fernandes Ode F, Kobayashi CC, Passos XS, Costa CR, Lemos JA, Souza-Júnior AH, Silva Mdo R.
    Rev Inst Med Trop Sao Paulo; 2005 Apr; 47(5):253-6. PubMed ID: 16302107
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
    Yildiran ST, Fothergill AW, Sutton DA, Rinaldi MG.
    Mycoses; 2002 Nov; 45(9-10):378-83. PubMed ID: 12421285
    [Abstract] [Full Text] [Related]

  • 18. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK, Souza Junior AH, Costa CR, Faganello J, Vainstein MH, Chagas AL, Souza AC, Silva MR.
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [Abstract] [Full Text] [Related]

  • 19. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
    Thompson GR, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF.
    Antimicrob Agents Chemother; 2009 Jan; 53(1):309-11. PubMed ID: 18955539
    [Abstract] [Full Text] [Related]

  • 20. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.
    Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW, Cryptococcal Disease Active Surveillance Group.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3065-9. PubMed ID: 11600357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.